Hepatic morphologic alterations in dogs given 1-t-butylamino-3-(2-chloro-5-methylphenoxy)-2-propanol hydrochloride.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D002082:Butylamines / Q000494:pharmacology; D004285:Dogs; D005260:Female; D008099:Liver / Q000033:anatomy & histology* / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D008854:Microscopy, Electron; D010647:Phenyl Ethers / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology*; D013194:Staining and Labeling; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D002082:Butylamines; D010647:Phenyl Ethers; D011412:Propanolamines; D000469:Alkaline Phosphatase